Results 131 to 140 of about 15,403 (210)

Persistence of newly prescribed 5-aminosalicylic acid in patients with ulcerative colitis: A nationwide comprehensive database study. [PDF]

PLoS One
Noda T, Kuwaki K, Machida M, Okumura Y, Nishioka Y, Myojin T, Imamura T.   +6 more
europepmc   +1 more source

Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy. [PDF]

Diseases
Sanapalli BKR, Deshpande A, Sanapalli V, Sigalapalli DK.   +3 more
europepmc   +1 more source

Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance. [PDF]

Biomedicines
Matsumoto H, Sasahira M, Go TT, Yo S, Ninomiya T, Osawa M, Handa O, Umegami E, Inoue R, Shiotani A.   +9 more
europepmc   +1 more source

Risk factors for non-responsiveness to 5-aminosalicylic acid in patients with ulcerative colitis identified using retrospective clinical study and Mendelian randomization. [PDF]

Sci Rep
Ye ZN, Liu XT, Gu YM, Mao SX, Liang DH, Zhan K, Lei HQ, Huang SG.   +7 more
europepmc   +1 more source

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis.

Digestion, 2023
Mikami Y, Tsunoda J, Suzuki S, Mizushima I, Kiyohara H, Kanai T.   +5 more
europepmc   +1 more source

Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial. [PDF]

Inflamm Bowel Dis
Fukuda T, Aoki Y, Kiyohara H, Yokoyama A, Nakazawa A, Yoshimatsu Y, Sugimoto S, Nanki K, Mikami Y, Fukuhara K, Mizuno S, Sujino T, Mutaguchi M, Takabayashi K, Morohoshi Y, Hosoda Y, Ogata H, Iwao Y, Naganuma M, Kanai T.   +19 more
europepmc   +1 more source

Successful Treatment of Refractory Ulcerative Colitis With 5-Aminosalicylic Acid Intolerance and Biologic Therapy Resistance Using Combined Granulocyte and Monocyte Adsorptive Apheresis. [PDF]

Cureus
Tanaka T, Hirano D, Ishimaru S, Arataki K.   +3 more
europepmc   +1 more source

The T120P or M172V mutation on rv2172c confers high level para-aminosalicylic acid resistance in Mycobacterium tuberculosis. [PDF]

Emerg Microbes Infect
Xu JT, Yu JF, Cheng T, Feng A, Yang P, Gu J, Yu HJ, Deng JY.   +7 more
europepmc   +1 more source

Investigating the effects of vitamin D3 and 5-aminosalicylic acid (Mesalazine) on the expression of virulence determinants in <i>Escherichia coli</i> isolated from patients with IBD and colorectal cancer. [PDF]

Gastroenterol Hepatol Bed Bench
Abolfazl Hosseininasab S, Saffari F, Tadjrobehkar O, Zandi H, Ahmadi B.   +4 more
europepmc   +1 more source

5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis. [PDF]

Nat Commun
Kim J, Ryu G, Seo J, Go M, Kim G, Yi S, Kim S, Lee H, Lee JY, Kim HS, Park MC, Shin DH, Shim H, Kim W, Lee SY.   +14 more
europepmc   +1 more source